{"database": "lobbying", "table": "lobbying_activities", "rows": [[1983848, "9f4a8bef-4022-4d2f-9ac2-f9a636f88622", "Q2", "AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION", 401103437, "AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION", 2017, "second_quarter", "PHA", "Determining the intended use of drugs and/or devices and using scientific exchange to share data on \"Off-label use\" (HR 1703/Medical Products Communications Act of 2017)", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-07-07T11:45:34.467000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1983848"], "units": {}, "query_ms": 0.40973699651658535, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}